Angelman Syndrome (AS) Market Assessment 2024: US and EU5 Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access
27 sept. 2024 04h16 HE
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Angelman Syndrome Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has been added...
Epilepsy Drugs Market Report and Global Forecast 2024-2030, Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health Companies, GSK, Novartis and Pfizer
06 mai 2024 04h04 HE
|
Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis" report has...
Levetiracetam Market Size and Outlook to [2022-2029] | Worldwide Analysis by Business Trends, Share, Future Demand, Progress Insight, Industry Statistics, Key Regions, Leading Players, Revenue and Forecast Research | Market Reports World
26 avr. 2022 07h11 HE
|
Market Reports World
Pune, April 26, 2022 (GLOBE NEWSWIRE) -- The latest global Levetiracetam Market research report 2022 provides detailed information about the market overview, modern trends, demand, and recent...
Global Epilepsy Drugs Market (2020 to 2027) - Featuring UCB, Eisai, H. Lundbeck and GW Pharmaceuticals
15 sept. 2021 04h28 HE
|
Research and Markets
Dublin, Sept. 15, 2021 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market, Global Forecast, Impact of COVID-19, Industry Trends, by Drugs Category, Growth, Opportunity Company Analysis" report has been...